文献速递中医内科中药与中成药合理使用

加味通窍活血汤经YAP/TAZ通路干预基底动脉延长扩张症小鼠

Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway.
PubMed 文献 · J Ethnopharmacol · 2023-05-04

结果显示JTHD可减轻基底动脉伸长、扩张和迂曲,减少血管平滑肌细胞凋亡,并下调YAP/TAZ通路表达。

要点

  • JTHD可改善BAD小鼠基底动脉的延长、扩张和迂曲。
  • JTHD减少血管平滑肌细胞凋亡并下调YAP/TAZ蛋白表达。
  • JTHD降低血清Lp-a并升高VEGF水平。

核心结论

  • JTHD抑制基底动脉延长、扩张和迂曲的机制可能与减少血管平滑肌细胞凋亡及下调YAP/TAZ通路表达有关。

研究设计与样本

  • 造模14天后给予药物干预2个月,随后进行LC-MS分析及多项病理和分子检测。

主要发现

  • 与假手术组相比,模型组小鼠血清VEGF水平显著降低,Lp-a水平明显升高。
  • 模型组基底动脉壁内膜中层出现内弹力层严重破坏、肌层萎缩和结缔组织玻璃样变,VSMCs凋亡增加。
  • 模型组基底动脉扩张、延长和迂曲明显,迂曲指数、延长指数、血管直径增加百分比和弯曲角度显著改善,血管YAP和TAZ蛋白表达显著升高(P<0.05,P<0.01)。
  • JTHD组干预2个月后,基底动脉延长、弯曲角度、血管直径增加百分比和迂曲指数较模型组显著降低。
  • JTHD组降低Lp-a分泌、增加VEGF含量,抑制内弹力层破坏、肌层萎缩和结缔组织玻璃样变,减少VSMCs凋亡并降低YAP和TAZ蛋白表达(P<0.05,P<0.01)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: The Jiawei Tongqiao Huoxue decoction (JTHD), composed of Acorus calamus var. angustatus Besser, Paeonia lactiflora Pall., Conioselinum anthriscoides 'Chuanxiong', Prunus persica (L.) Batsch, Ziziphus jujuba Mill., Carthamus tinctorius L., Pueraria montana var. lobata (Willd.) Maesen & S.M.Almeida ex Sanjappa & Predeep, Zingiber officinale Roscoe, Leiurus quinquestriatus, and Moschus berezovskii Flerov, was developed based on Tongqiao Huoxue decoction in Wang Qingren's "Yilin Gaicuo" in the Qing Dynasty. It has the effect of improving not only the blood flow velocity of vertebral and basilar arteries but also the blood flow parameters and wall shear stress. Especially in recent years, the potential efficacy of traditional Chinese medicine (TCM) for the treatment of basilar artery dolichoectasia (BAD) has attracted great attention as there are still no specific remedies for this disease. However, its molecular mechanism has not been elucidated. To identify the potential mechanisms of JTHD will help to intervene BAD and provide a reference for its clinical application. AIM OF THE STUDY: This study aims to establish a mouse model of BAD and explore the mechanism of JTHD regulating yes-associated protein/transcriptional co-activator with PDZ-binding motif (YAP/TAZ) pathway for attenuating BAD mice development. MATERIALS AND METHODS: Sixty post-modeling C57/BL6 female mice were randomly divided into sham-operated, model, atorvastatin calcium tablet, low-dose JTHD, and high-dose JTHD groups. After 14 days of modeling, the pharmacological intervention was given for 2 months. Then, JTHD was analyzed by liquid chromatography-tandem mass spectrometry (LC-MS). ELISA was utilized to detect the changes in vascular endothelial growth factor (VEGF) and lipoprotein a (Lp-a) in serum. EVG staining was conducted to observe the pathological changes of blood vessels. TUNEL method was employed to detect the apoptosis rate of vascular smooth muscle cells (VSMCs). Micro-CT and ImagePro Plus software were used to observe and calculate the tortuosity index, lengthening index, percentage increase in vessel diameter, and tortuosity of the basilar artery vessels in mice. Western blot analysis was performed to detect the expression levels of YAP and TAZ proteins in the vascular tissues of mice. RESULTS: Many effective compounds such as choline, tryptophan, and leucine with anti-inflammation and vascular remodeling were identified in the Chinese medicine formula by LC-MS analysis. The serum levels of VEGF in the model mice decreased significantly while the levels of Lp-a increased obviously compared with those in the sham-operated group. The intima-media of the basilar artery wall showed severe disruption of the internal elastic layer, atrophy of the muscular layer, and hyaline changes of the connective tissue. Apoptosis of VSMCs added. Dilatation, elongation, and tortuosity of the basilar artery became notable, and tortuosity index, lengthening index, percentage increase in vessel diameter, and bending angle remarkably improved. The expression levels of YAP and TAZ protein in blood vessels elevated conspicuously (P < 0.05, P < 0.01). JTHD group markedly reduced the lengthening, bending angle, percentage increase in vessel diameter, and tortuosity index of basilar artery compared with the model group after 2 months of pharmacological intervention. The group also decreased the secretion of Lp-a and increased the content of VEGF. It inhibited the destruction of the internal elastic layer, muscular atrophy, and hyaline degeneration of connective tissue in basilar artery wall. The apoptosis of VSMCs was decreased, and the expression levels of YAP and TAZ proteins were abated (P < 0.05, P < 0.01). CONCLUSIONS: The mechanism of inhibition of basilar artery elongation, dilation, and tortuosity by JTHD, which has various anti-BAD effective compound components, may be related to the reduction in VSMCs apoptosis and downregulation of YAP/TAZ pathway expression.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Liu FX, Zhang DP, Ma YM, et al. Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway. J Ethnopharmacol. 2023. PMID: 37149070. doi:10.1016/j.jep.2023.116599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。